维梧资本完成第九期基金募集，14.3亿美元用于投资医疗健康和生命科学公司 维梧资本完成第九期基金募集，14.3亿美元用于投资医疗健康和生命科学公司 全部新闻, 维梧新闻 维梧资本完成第九期基金募集，14.3亿美元用于投资医疗健康和生命科学公司artrix2019-10-30T13:46:10-07:00十月 30th, 2019|Read More
12 VCs who matter in biotech, but you never read about 12 VCs who matter in biotech, but you never read about 全部新闻, 维梧新闻 12 VCs who matter in biotech, but you never read aboutartrix2019-11-05T22:26:04-08:00十月 9th, 2019|Read More
Swift Health Systems Raises $45 Million in Series C Funding Swift Health Systems Raises $45 Million in Series C Funding 全部新闻, 维梧新闻 Swift Health Systems Raises $45 Million in Series C Fundingartrix2020-01-22T00:32:54-08:00十月 8th, 2019|Read More
Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare 全部新闻, 维梧新闻 Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcareartrix2020-01-22T00:33:38-08:00七月 30th, 2019|Read More
Impel NeuroPharma完成6750万美元的D轮融资 Impel NeuroPharma完成6750万美元的D轮融资 全部新闻, 美国投资项目, 维梧新闻 Impel NeuroPharma完成6750万美元的D轮融资artrix2019-10-24T03:25:40-07:00十二月 6th, 2018|Read More
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China 全部新闻, 美国投资项目, 维梧新闻 Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in Chinaartrix2019-10-24T03:22:56-07:00十一月 8th, 2018|Read More
Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资，用于推进NASH和癌症药物的研发 Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资，用于推进NASH和癌症药物的研发 全部新闻, 美国投资项目, 维梧新闻 Terns Pharmaceuticals与上海拓臻生物科技有限公司 完成8000万美元B轮融资，用于推进NASH和癌症药物的研发artrix2019-10-24T03:22:19-07:00十月 30th, 2018|Read More
Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities 全部新闻, 维梧新闻 Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equitiesartrix2019-10-19T05:31:53-07:00九月 11th, 2018|Read More
维梧资本机会基金获超额认购，完成6.35亿美元融资 维梧资本机会基金获超额认购，完成6.35亿美元融资 全部新闻, 维梧新闻 维梧资本机会基金获超额认购，完成6.35亿美元融资artrix2019-10-24T02:57:00-07:00九月 11th, 2018|Read More
诺诚健华研发平台受青睐，维梧资本领投5500万美元融资 诺诚健华研发平台受青睐，维梧资本领投5500万美元融资 全部新闻, 维梧新闻 诺诚健华研发平台受青睐，维梧资本领投5500万美元融资artrix2019-10-24T02:55:17-07:00二月 6th, 2018|Read More
维梧资本领投欧米尼医药C轮融资 升级版桥梁策略首试新药研发市场 维梧资本领投欧米尼医药C轮融资 升级版桥梁策略首试新药研发市场 全部新闻, 维梧新闻 维梧资本领投欧米尼医药C轮融资 升级版桥梁策略首试新药研发市场artrix2019-10-24T02:52:06-07:00十二月 11th, 2017|Read More
Vivo Capital’s Evolving “Bridge Strategy” Helps Nanjing King-friend Go Public Vivo Capital’s Evolving “Bridge Strategy” Helps Nanjing King-friend Go Public 全部新闻, 维梧新闻 Vivo Capital’s Evolving “Bridge Strategy” Helps Nanjing King-friend Go Publicartrix2019-10-19T05:32:24-07:00八月 1st, 2017|Read More
助力南京健友成功上市 维梧资本“桥梁战略”全面升级 助力南京健友成功上市 维梧资本“桥梁战略”全面升级 全部新闻, 维梧新闻 助力南京健友成功上市 维梧资本“桥梁战略”全面升级artrix2019-10-24T01:46:10-07:00八月 1st, 2017|Read More
Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Million 全部新闻, 维梧新闻 Vivo Capital Closes First Healthcare Venture Capital Focused Fund at Over $100 Millionartrix2019-10-19T05:32:32-07:00六月 13th, 2016|Read More
维梧资本设立前期创投基金，首期募集资金超过一亿美元 维梧资本设立前期创投基金，首期募集资金超过一亿美元 全部新闻, 维梧新闻 维梧资本设立前期创投基金，首期募集资金超过一亿美元artrix2019-10-24T01:40:30-07:00六月 13th, 2016|Read More
维梧资本公开认购巨星国际股份 助力企业进军医疗耗材领域 维梧资本公开认购巨星国际股份 助力企业进军医疗耗材领域 全部新闻, 维梧新闻 维梧资本公开认购巨星国际股份 助力企业进军医疗耗材领域artrix2019-10-24T01:37:17-07:00九月 2nd, 2015|Read More
维梧资本领投更美 APP 抢滩国内移动医疗领域 维梧资本领投更美 APP 抢滩国内移动医疗领域 全部新闻, 维梧新闻 维梧资本领投更美 APP 抢滩国内移动医疗领域artrix2019-10-24T01:35:04-07:00八月 13th, 2015|Read More
维梧低调支持长春长生资产交易 资本市场前景看好 维梧低调支持长春长生资产交易 资本市场前景看好 全部新闻, 维梧新闻 维梧低调支持长春长生资产交易 资本市场前景看好artrix2019-10-24T01:31:41-07:00七月 9th, 2015|Read More
成功助推海利生物上市 维梧资本大健康投资布局渐清晰 成功助推海利生物上市 维梧资本大健康投资布局渐清晰 全部新闻, 维梧新闻 成功助推海利生物上市 维梧资本大健康投资布局渐清晰artrix2019-10-24T01:10:54-07:00六月 26th, 2015|Read More
维梧资本第八期7.5亿美元募资超额完成 维梧资本第八期7.5亿美元募资超额完成 全部新闻, 维梧新闻 维梧资本第八期7.5亿美元募资超额完成artrix2019-10-24T01:08:55-07:00三月 18th, 2015|Read More
Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater China 全部新闻, 维梧新闻 Vivo Capital Closes Oversubscribed $750 Million 8th Fund to Invest in Healthcare in the U.S. and Greater Chinaartrix2019-10-19T05:32:39-07:00三月 17th, 2015|Read More
Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China 全部新闻, 维梧新闻 Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater Chinaartrix2019-10-19T05:32:47-07:00一月 3rd, 2012|Read More
